In 2024, several human infections with highly pathogenic clade 2.3.4.4b bovine influenza H5N1 viruses in the United States raised concerns about their capability for bovine-to-human or even human-to-human transmission. In this study, analysis of the hemagglutinin (HA) from the first-reported human-infecting bovine H5N1 virus (A/Texas/37/2024, Texas) revealed avian-type receptor binding preference. Notably, a GlnLeu substitution switched Texas HA binding specificity to human-type receptors, which was enhanced when combined with an AsnLys mutation. Crystal structures of the Texas HA with avian receptor analog LSTa and its GlnLeu mutant with human receptor analog LSTc elucidated the structural basis for this preferential receptor recognition. These findings highlight the need for continuous surveillance of emerging mutations in avian and bovine clade 2.3.4.4b H5N1 viruses.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1126/science.adt0180 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comments on 'Should the equine community be concerned about the emergence of the H5N1 subtype of highly pathogenic avian influenza in US cattle?'.
Equine Vet J
December 2024
Royal GD, Department of Small Ruminants, Horses and Companion Animals, Deventer, The Netherlands.
Targets of influenza human T-cell response are mostly conserved in H5N1.
mBio
December 2024
Center for Vaccine Innovation, La Jolla Institute for Immunology (LJI), La Jolla, California, USA.
Frequent recent spillovers of subtype H5N1 clade 2.3.4.
View Article and Find Full Text PDFAre we cultivating the perfect storm for a human avian influenza pandemic?
Biol Res
December 2024
Laboratory of Cellular and Molecular Inmunology, Fundacion Ciencia & Vida, Universidad San Sebastian, Avda. del Valle Norte 725, Huechuraba, 8580702, Santiago, Region Metropolitana, Chile.
The emergence of highly pathogenic avian influenza (HPAI) A H5N1 virus in dairy cattle marks a troubling new chapter in the ongoing battle against zoonotic diseases. Since its initial detection in 1955, the H5N1 virus has primarily been associated with poultry, posing significant threats to both animal and human health. However, recent outbreaks in U.
View Article and Find Full Text PDFAn influenza mRNA vaccine protects ferrets from lethal infection with highly pathogenic avian influenza A(H5N1) virus.
Sci Transl Med
December 2024
Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
The global spread of the highly pathogenic avian influenza (HPAI) A(H5N1) virus poses a serious pandemic threat, necessitating the swift development of effective vaccines. The success of messenger RNA (mRNA) vaccine technology in the COVID-19 pandemic, marked by its rapid development and scalability, demonstrates its potential for addressing other infectious threats, such as HPAI A(H5N1). We therefore evaluated mRNA vaccine candidates targeting panzootic influenza A(H5) clade 2.
View Article and Find Full Text PDFSensors for surveillance of RNA viruses: a One Health perspective.
Lancet Microbe
December 2024
Department of Biomedical Engineering, Zhejiang University, Hangzhou, China; Research Center for Frontier Fundamental Studies, Zhejiang Lab, Hangzhou, China. Electronic address:
RNA viruses, especially those capable of cross-species transmission, pose a serious threat to human, animal, and environmental health, as exemplified by the 2024 outbreak of the highly pathogenic avian influenza H5N1 virus in cattle, unpasteurised milk, and workers on dairy farms in the USA. This escalating risk of a new RNA virus pandemic highlights the urgent need to implement One Health strategies. However, the centralised virus detection systems currently in use fall short of meeting the required level of virus surveillance and infection diagnosis, particularly in resource-limited regions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!